219 related articles for article (PubMed ID: 31408512)
1. Mitochondrial DNA copy number in peripheral blood leukocytes is associated with biochemical recurrence in prostate cancer patients in African Americans.
Xu J; Chang WS; Tsai CW; Bau DT; Davis JW; Thompson TC; Logothetis CJ; Gu J
Carcinogenesis; 2020 May; 41(3):267-273. PubMed ID: 31408512
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial DNA copy number in peripheral blood leukocytes and the aggressiveness of localized prostate cancer.
Tu H; Gu J; Meng QH; Kim J; Davis JW; He Y; Wagar EA; Thompson TC; Logothetis CJ; Wu X
Oncotarget; 2015 Dec; 6(39):41988-96. PubMed ID: 26515605
[TBL] [Abstract][Full Text] [Related]
3. Methylation of subtelomeric repeat D4Z4 in peripheral blood leukocytes is associated with biochemical recurrence in localized prostate cancer patients.
Han Y; Xu J; Kim J; Wu X; Gu J
Carcinogenesis; 2017 Aug; 38(8):821-826. PubMed ID: 28854562
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte telomere length is associated with aggressive prostate cancer in localized African American prostate cancer patients.
Tsai CW; Chang WS; Xu J; Xu Y; Huang M; Pettaway C; Bau DT; Gu J
Carcinogenesis; 2020 Sep; 41(9):1213-1218. PubMed ID: 32614411
[TBL] [Abstract][Full Text] [Related]
5. Association between pre-diagnostic leukocyte mitochondrial DNA copy number and survival among colorectal cancer patients.
Yang K; Forman MR; Graham BH; Monahan PO; Giovannucci EL; De Vivo I; Chan AT; Nan H
Cancer Epidemiol; 2020 Oct; 68():101778. PubMed ID: 32674053
[TBL] [Abstract][Full Text] [Related]
6. Alterations of telomere length and mtDNA copy number are associated with overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
Bao D; Ba Y; Zhou F; Zhao J; Yang Q; Ge N; Guo X; Wu Z; Zhang H; Yang H; Wan S; Xing J
Cancer Chemother Pharmacol; 2016 Oct; 78(4):791-9. PubMed ID: 27558242
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood mitochondrial DNA copy number is associated with prostate cancer risk and tumor burden.
Zhou W; Zhu M; Gui M; Huang L; Long Z; Wang L; Chen H; Yin Y; Jiang X; Dai Y; Tang Y; He L; Zhong K
PLoS One; 2014; 9(10):e109470. PubMed ID: 25279731
[TBL] [Abstract][Full Text] [Related]
8. High leukocyte mitochondrial DNA copy number contributes to poor prognosis in breast cancer patients.
Zhang W; Lin S; Zeng B; Chen X; Chen L; Chen M; Guo W; Lin Y; Yu L; Hou J; Li Y; Li S; Jin X; Cai W; Zhang K; Nie Q; Chen H; Li J; He P; Cai Q; Qiu Y; Wang C; Fu F
BMC Cancer; 2023 Apr; 23(1):377. PubMed ID: 37098487
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients.
Xu J; Chang WS; Tsai CW; Bau DT; Xu Y; Davis JW; Thompson TC; Logothetis CJ; Gu J
EBioMedicine; 2020 Feb; 52():102616. PubMed ID: 31981976
[TBL] [Abstract][Full Text] [Related]
10. Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison.
Ritch CR; Morrison BF; Hruby G; Coard KC; Mayhew R; Aiken W; Benson MC; McKiernan JM
BJU Int; 2013 Apr; 111(4 Pt B):E186-90. PubMed ID: 23107067
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen density predicts favorable pathology and biochemical recurrence in patients with intermediate-risk prostate cancer.
Kang HW; Jung HD; Lee JY; Kwon JK; Jeh SU; Cho KS; Ham WS; Choi YD
Asian J Androl; 2016; 18(3):480-4. PubMed ID: 26178393
[TBL] [Abstract][Full Text] [Related]
12. Primary whole-gland ablation for localized prostate cancer with high-intensity focused ultrasound: The important predictors of biochemical recurrence.
Chen PY; Chiang PH; Liu YY; Chuang YC; Cheng YT
Int J Urol; 2018 Jun; 25(6):615-620. PubMed ID: 29756298
[TBL] [Abstract][Full Text] [Related]
13. Primary Gleason grade 4 impact on biochemical recurrence after permanent interstitial brachytherapy in Japanese patients with low- or intermediate-risk prostate cancer.
Uesugi T; Saika T; Edamura K; Nose H; Kobuke M; Ebara S; Abarzua F; Katayama N; Yanai H; Nasu Y; Kumon H
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e219-23. PubMed ID: 21640517
[TBL] [Abstract][Full Text] [Related]
14. Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.
Özsoy M; D'Andrea D; Moschini M; Foerster B; Abufaraj M; Mathieu R; Briganti A; Karakiewicz PI; Roupret M; Seitz C; Czech AK; Susani M; Shariat SF
Urol Oncol; 2018 Apr; 36(4):158.e1-158.e6. PubMed ID: 29288003
[TBL] [Abstract][Full Text] [Related]
15. Tumor volume, surgical margin, and the risk of biochemical recurrence in men with organ-confined prostate cancer.
Song C; Kang T; Yoo S; Jeong IG; Ro JY; Hong JH; Kim CS; Ahn H
Urol Oncol; 2013 Feb; 31(2):168-74. PubMed ID: 21719325
[TBL] [Abstract][Full Text] [Related]
16. Prognostic utility of cell cycle progression score in men with prostate cancer after primary external beam radiation therapy.
Freedland SJ; Gerber L; Reid J; Welbourn W; Tikishvili E; Park J; Younus A; Gutin A; Sangale Z; Lanchbury JS; Salama JK; Stone S
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):848-53. PubMed ID: 23755923
[TBL] [Abstract][Full Text] [Related]
17. Pre-diagnostic leukocyte mitochondrial DNA copy number and colorectal cancer risk.
Yang K; Li X; Forman MR; Monahan PO; Graham BH; Joshi A; Song M; Hang D; Ogino S; Giovannucci EL; De Vivo I; Chan AT; Nan H
Carcinogenesis; 2019 Dec; 40(12):1462-1468. PubMed ID: 31556446
[TBL] [Abstract][Full Text] [Related]
18. Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapies.
Briganti A; Joniau S; Gandaglia G; Cozzarini C; Sun M; Tombal B; Haustermans K; Hinkelbein W; Shariat SF; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):960-7. PubMed ID: 24351411
[TBL] [Abstract][Full Text] [Related]
19. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.
Abdollah F; Sood A; Sammon JD; Hsu L; Beyer B; Moschini M; Gandaglia G; Rogers CG; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
Eur Urol; 2015 Sep; 68(3):497-505. PubMed ID: 26119559
[TBL] [Abstract][Full Text] [Related]
20. A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer.
Cullen J; Rosner IL; Brand TC; Zhang N; Tsiatis AC; Moncur J; Ali A; Chen Y; Knezevic D; Maddala T; Lawrence HJ; Febbo PG; Srivastava S; Sesterhenn IA; McLeod DG
Eur Urol; 2015 Jul; 68(1):123-31. PubMed ID: 25465337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
